Christine van Heek
Founder bei Bio Point Group LLC
Vermögen: 2 571 $ am 31.03.2024
Profil
Christine van Heek is the founder and the Managing Partner of Bio Point Group LLC, which was founded in 2003.
She also held the position of President-Therapeutics Division at Genzyme Corp.
from 1991 to 2003.
Additionally, Ms. van Heek served as an Independent Director at Concert Pharmaceuticals, Inc., an Independent Director at Affymax, Inc. from 2007 to 2014, and an Independent Non-Executive Director at Visioneering Technologies, Inc. from 2008 to 2022.
She was also a Principal at Genentech, Inc. and Caremark, Inc. Ms. van Heek holds an MBA from Lindenwood University and an undergraduate degree from the University of Iowa, which was conferred in 1979.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.07.2022 | 21 895 ( 0,04% ) | 2 571 $ | 31.03.2024 |
Aktive Positionen von Christine van Heek
| Unternehmen | Position | Beginn |
|---|---|---|
| Bio Point Group LLC | Founder | 01.01.2003 |
Ehemalige bekannte Positionen von Christine van Heek
| Unternehmen | Position | Ende |
|---|---|---|
| VISIONEERING TECHNOLOGIES, INC. | Director/Board Member | 01.05.2022 |
| AFFYMAX, INC. | Director/Board Member | 01.11.2014 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2003 |
| CONCERT PHARMACEUTICALS, INC. | Director/Board Member | - |
| Caremark, Inc. | Corporate Officer/Principal | - |
Ausbildung von Christine van Heek
| Lindenwood University | Masters Business Admin |
| University of Iowa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| VISIONEERING TECHNOLOGIES, INC. | Electronic Technology |
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
| Bio Point Group LLC | |
| Caremark, Inc. |
